Evaluating the Clinical Utility of Periprocedural Flat-Panel Computed Tomography in Acute StrokeNew imaging data helps doctors monitor stroke treatment safety

This meta-analysis evaluates the utility of periprocedural flat-panel computed tomography (FPCT) in patients undergoing endovascular treatment for acute ischemic stroke. By analyzing data from 4,139 patients in angiography suites, the study examines various imaging markers, including intraparenchymal, subarachnoid, and intravascular hyperattenuations, to determine their correlation with clinical outcomes and procedural complications.

Intraparenchymal hyperattenuations were identified in approximately 49% of the study population. These findings were strongly associated with adverse events; specifically, the presence of these hyperattenuations was linked to a significantly higher risk of any intracranial hemorrhage. Furthermore, these findings correlated with an increased likelihood of parenchymal hematoma, suggesting that such imaging markers may serve as indicators of tissue fragility or procedural risk.

Conversely, the presence of intraparenchymal hyperattenuations was inversely associated with favorable clinical outcomes. Patients exhibiting these hyperattenuations were significantly less likely to achieve a modified Rankin Scale score of 0-2 at 90 days. This suggests that these specific radiological signs may reflect established tissue damage that limits the potential for functional recovery following successful recanalization.

Subarachnoid hyperattenuations were observed in 23% of cases. While these were also associated with poorer outcomes compared to patients without such findings, the correlation was less pronounced than that seen with intraparenchymal hyperattenuations. These findings highlight the importance of multi-modal imaging in identifying different types of parenchymal and extra-axial complications during the intervention.

Intravascular hyperattenuations, also known as the distal occlusion tracker sign, were present in 35% of the cohort. Notably, this marker demonstrated high specificity (93%) for identifying residual distal occlusions. This high specificity suggests that intravascular hyperattenuations can be a reliable indicator for clinicians to determine if additional maneuvers are necessary to achieve complete reperfusion.

Clinically, FPCT provides real-time neurovascular and parenchymal assessment. It allows for immediate intraprocedural decision-making regarding the necessity of adjunctive maneuvers or specific drug administrations. By identifying both risks, such as hemorrhage, and technical hurdles, like distal occlusions, FPCT serves as a valuable tool in the angiography suite.

While the findings are promising, the study notes a potential for selection bias, which may lead to a slight overreporting of certain imaging signs. Therefore, while these markers are highly relevant for intraprocedural guidance, further prospective validation is required to fully establish their role in standard clinical decision-making protocols. The integration of FPCT offers a nuanced view of the evolving stroke landscape during active intervention.